Literature DB >> 16305984

How often should a port-A-cath be flushed?

Y S Kuo1, B Schwartz, J Santiago, P S Anderson, A L Fields, Gary L Goldberg.   

Abstract

While it is important during treatment to flush the port-A-cath (PAC) with heparin regularly, catheter maintenance needs to be evaluated in those patients who, after completion of therapy, retained their ports for extended periods of time. The manufacturer has recommended monthly accession to maintain catheter patency and function. Our objective is to demonstrate that a longer interval between maintenance accessions of PACs still may be medically safe, convenient, and more efficient. We performed a retrospective review of all patients who had undergone PAC insertion from 1988 to 1993 at the Albert Einstein College of Medicine, and from 1997 to 2002 at the New York Hospital Medical Center of Queens. An adequate maintenance time is defined as a period of at least 6 months without chemotherapy or total parenteral nutrition. Data collected included date and location of PAC insertion, date of PAC accessions, PAC complications, and results of attempts at flushing the catheters with no venous blood return. All data were entered into an Excel spreadsheet and analyzed. The difference in interval accessions in patients without any complication to patients with complication was calculated using the Mann-Whitney "U" test. A total of 73 patients were included in the study. Compliance with visits for PAC maintenance varied considerably with the individual median accession times varying between 28 and 262 days with an overall median of 42 days. The individual means ranged from 29.5 to 244 days with an overall mean of 53.6 days. Seven patients in the group had episodes where the provider was unable to draw blood from the port during routine accession. The average intervals between accessions for each of these patients ranged from 38 to 244 days. The average intervals of accession among those patients who had no blood return during PAC accession was 79 days, versus 63 days for those without any difficulty. The difference was not statistically significant (p>0.05). Monthly maintenance of PAC is excessive, inconvenient for the patients, and expensive. Extending the interval of PAC maintenance proves to be medically safe and beneficial to the patients, the physicians and the health care system. Our clinical experience suggests that less frequent accessions of PACs is safe and feasible. We strongly advocate future prospective investigation of alternative PAC maintenance protocols in gynecologic cancer patients.

Entities:  

Mesh:

Year:  2005        PMID: 16305984     DOI: 10.1080/07357900500276923

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  9 in total

Review 1.  Focus on peripherally inserted central catheters in critically ill patients.

Authors:  Paolo Cotogni; Mauro Pittiruti
Journal:  World J Crit Care Med       Date:  2014-11-04

2.  Central venous port systems as an integral part of chemotherapy.

Authors:  Ulf K Teichgräber; Robert Pfitzmann; Herbert A F Hofmann
Journal:  Dtsch Arztebl Int       Date:  2011-03-04       Impact factor: 5.594

Review 3.  Thrombolytic therapy for central venous catheter occlusion.

Authors:  Jacquelyn L Baskin; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Ching-Hon Pui; Scott C Howard
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 4.  Management of occlusion and thrombosis associated with long-term indwelling central venous catheters.

Authors:  Jacquelyn L Baskin; Ching-Hon Pui; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Scott C Howard
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

5.  Effect of port-care frequency on venous port catheter-related complications in cancer patients.

Authors:  Hatice Odabas; Nuriye Yıldırım Ozdemir; Ipek Ziraman; Sercan Aksoy; Huseyin Abali; Berna Oksuzoglu; Metin Isik; Burak Civelek; Dogan Dede; Nurullah Zengin
Journal:  Int J Clin Oncol       Date:  2013-08-27       Impact factor: 3.402

Review 6.  Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients.

Authors:  Francisca Jane Gomes de Oliveira; Andrea Bezerra Rodrigues; Islane Costa Ramos; Joselany Áfio Caetano
Journal:  Rev Lat Am Enfermagem       Date:  2020-06-19

7.  Current port maintenance strategies are insufficient: View based on actual presentations of implanted ports.

Authors:  Pin-Li Chou; Jui-Ying Fu; Chia-Hui Cheng; Yen Chu; Ching-Feng Wu; Po-Jen Ko; Yun-Hen Liu; Ching-Yang Wu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.889

8.  Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments.

Authors:  Sang-Bo Oh; Kwonoh Park; Jae-Joon Kim; So-Yeon Oh; Ki-Sun Jung; Byung-Soo Park; Gyung-Mo Son; Hyun-Sung Kim; Dong-Hyun Kim; Hyuk-Jae Jung; Sang-Su Lee
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

9.  Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial.

Authors:  Melania Cia-Arriaza; Sandra Cabrera-Jaime; Rosario Cano-Soria; Mireia Manzano-Castro; Margarita Domínguez-Gómez; Dolores M Prieto-Arenas; Angeles Benito-Yagüe; Adela Sánchez-Martín; Cristina González-Alonso; Paz Fernández-Ortega
Journal:  Asia Pac J Oncol Nurs       Date:  2022-05-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.